PharVision Advisers’s Emerson Electric EMR Stock Holding History

PharVision Advisers’s Portfolio EMR Stock Details EMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,688	Closed	-$295K	–	311
2025 Q1	$295K	Buy	+2,688	New	+$324K	0.41%	96

Other funds holding EMR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's EMR Position: Q2 2025 in Review

PharVision Advisers sold out of Emerson Electric (EMR) in Q2 2025, closing a stake of 2,688 shares — an estimated $295K sold.

PharVision Advisers first reported a position in EMR in Q1 2025 and held it in 1 quarter. The position peaked at $295K in Q1 2025. 2,135 funds tracked by Wall St. Rank hold EMR as of Q2 2025.

PharVision Advisers reported no remaining Emerson Electric position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 2,688 Emerson Electric shares in Q2 2025, an estimated $295K.
PharVision Advisers first reported a position in Emerson Electric in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Emerson Electric position peaked at $295K in Q1 2025.
2,135 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.